TBG Diagnostics Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares TBG Diagnostics Ltd with three other
companies in this sector in AUSTRALIA :
Auscann Group Holdings Ltd
sales of 861,770.00 Australian Dollars [US$524,507.69 ]
(956,472.00 Australian Dollars [US$582,147.12 ]
(2.92 million Australian Dollars [US$1.78 million]
of which 82%
was HyperImmune Products).
TBG Diagnostics Ltd reported sales of A$3.44 million (US$2.10 million)
December of 2019.
increase of 6.3%
versus 2018, when the company's sales were A$3.24 million.
Despite this increase, sales are still
below the level achieved in 2017, when TBG Diagnostics Ltd
reported sales of A$4.11 million.